Review: Phenotypes and origins of myeloid-derived suppressor

A new review was published in Oncotarget's Volume 13 on November 17, 2022, entitled, "Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more."

Related Keywords

Japan , Aizu , Fukushima , Nippon , Daigo Yoshimori , Kotaro Nanno , Masahiko Shibata , Satoshi Muto , Yoshiyuki Suzuki , Takashi Yazawa , Kousaku Mimura , Shungo Endo , Takafumi Watanabe , Takahiro Nakajima , Seiichi Takenoshita , Koji Kono , Bange Kousei , Makoto Takada , Norio Inoue , Kazunoshin Tachibana , Aizu Oncology Consortium , Nippon Medical School , Lab Diagnostics Automation , Fukushima Medical University , Lab Diagnostics Automation Industry , Automation Industry Focus , Tomoyuki Momma , Aizu Chuo Hospital , Bange Kousei General Hospital , Cancer , Ancer Immunotherapy , Hospital , Immunosuppression , Immunotherapy , Alignant , Obesity , Ncology , Research , Humor ,